ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1018

A 32-Mer Aggrecan Fragment Generated through Adamts-4/5 and MMP-Mediated Cleavage Can Directly Excite Nociceptive Neurons

Rachel E. Miller1, Richard J. Miller2, Abdelhak Belmadani3, Suzanne Golub4, Amanda J. Fosang4 and Anne-Marie Malfait5, 1Biochemistry, Rush University Medical Center, Chicago, IL, 2Molecular Biochemistry and Pharmacology, Northwestern University, Chicago, IL, 3Northwestern University, Chicago, IL, 4University of Melbourne, Melbourne, Australia, 5Rush University Medeical Center, Chicago, IL

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: cartilage, osteoarthritis and pain

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Pain: Basic Aspects

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:

Cleavage of aggrecan in the interglobular domain (E373–374A) by ADAMTS-4/5 is an early event in osteoarthritis pathogenesis. Further cleavage by MMPs (N341–342F) releases a 32-amino-acid fragment, FFGVGGEDDITIQTVTWPDLELPLPRNVTEGE. We recently reported that this 32-mer acts as a TLR2-dependent damage-associated molecular pattern on chondrocytes and synovial fibroblasts. Here, we hypothesized that this aggrecan fragment may directly excite nociceptors.

Methods:

DRG cells (L3-L5) were isolated from adult C57BL/6 wild-type, Tlr4-null, or Tlr2-null mice and cultured. Direct effects of synthetic 32-mer on DRG neurons were monitored by examining intracellular calcium (Ca)i mobilization or production of  MCP-1. For Ca mobilization assays, cells were loaded with Fura-2 and responses to 32-mer or scrambled peptide recorded in >100 neurons. For MCP-1 stimulation assays, cells were treated overnight with 32-mer (0.3-30 μM) or with scrambled control. Supernatants were collected for MCP-1 ELISA, because we have previously shown that MCP-1 is a key mediator of pain in experimental OA.

For ex vivo imaging assays, intact DRG were isolated from Pirt-GCaMP3 mice, which express the fluorescent calcium indicator, GCaMP3, in 90% of sensory neurons through the Pirt promoter. Explants, placed in a perfusion chamber and imaged using a spinning disk confocal microscope, were stimulated by injecting 10 µL of 1 mM 32-mer into a continuously running perfusion chamber with a 1 mL-volume. ImageJ analysis was performed to determine change in fluorescence intensity with time.

Results:

Cultured DRG neurons rapidly responded to 32-mer, but not scrambled control peptide, as indicated by increased (Ca)i in 20% of neurons. This suggests that DRG neurons express excitatory receptors for this protein fragment. Responses were mostly seen in small-to-medium-diameter neurons (nociceptors) that were also responsive to capsaicin, which demonstrates that TRPV1-expressing nociceptors are capable of responding to 32-mer. In order to show that 32-mer responses are not an artifact of cell culture, calcium imaging was also performed using intact DRG from Pirt-GCaMP3 mice. Within DRG explants, 7% of neurons responded to 32-mer peptide, while scrambled peptide elicited no responses.

Overnight stimulation of cultured DRG cells with either 3 or 30 μM 32-mer peptide resulted in significant upregulation in MCP-1 protein production compared to unstimulated cells (3.1-fold (3 μM) and 3.5-fold (30 μM), p<0.001). The highest concentration of scrambled peptide (30 μM) did not induce MCP-1 production (0.8-fold, p=0.09 vs. unstimulated).

In order to investigate which receptor mediates the upregulation of MCP-1, DRG cells were cultured from Tlr2 null or Tlr4 null mice. Stimulation with 32-mer peptide (3 μM) produced increased MCP-1 in Tlr4 null DRG cells compared to unstimulated cells (3.3-fold, p<0.01), but not in Tlr2null cells (0.9-fold, p=0.5), suggesting that these effects are mediated through TLR2.

Conclusion:

Nociceptors can respond to a specific 32-mer cleavage product of aggrecan through TLR2. This pathway may contribute to the development of OA-associated pain, a hypothesis currently being tested in in vivo models.


Disclosure: R. E. Miller, None; R. J. Miller, None; A. Belmadani, None; S. Golub, None; A. J. Fosang, None; A. M. Malfait, None.

To cite this abstract in AMA style:

Miller RE, Miller RJ, Belmadani A, Golub S, Fosang AJ, Malfait AM. A 32-Mer Aggrecan Fragment Generated through Adamts-4/5 and MMP-Mediated Cleavage Can Directly Excite Nociceptive Neurons [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/a-32-mer-aggrecan-fragment-generated-through-adamts-45-and-mmp-mediated-cleavage-can-directly-excite-nociceptive-neurons/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-32-mer-aggrecan-fragment-generated-through-adamts-45-and-mmp-mediated-cleavage-can-directly-excite-nociceptive-neurons/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology